Monitoring RGC open interest helps you see where real money is positioned on Regencell Bioscience Holdings Ltd's options and which strikes are attracting the most commitment from traders. Regencell Bioscience Holdings Ltd's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor RGC options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising RGC options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Regencell Bioscience Holdings Ltd to settle.
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where RGC open interest is concentrated. Our scanner maps Regencell Bioscience Holdings Ltd's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Regencell Bioscience Holdings Ltd's options open interest as the signal it is, not as an afterthought.
